Blue Water Acquisition Corp. III

What they do

The company has no material operations and has not commenced operations, generating no operating revenue. It was formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, and expects to focus on biotechnology, healthcare and technology companies. All activity from inception through June 30, 2026 relates to formation, the initial public offering, and identifying and negotiating a potential business combination.

Revenue drivers

• No operating revenue — The company will not generate any operating revenues until after completion of an initial business combination, at the earliest.
• Non-operating income — It generates non-operating income in the form of interest income on cash and cash equivalents and dividend income from marketable securities derived from IPO proceeds.
• IPO trust proceeds — The June 11, 2025 initial public offering of 25,300,000 units at $10.00 generated gross proceeds of $253,000,000.
• Private placement proceeds — A simultaneous private placement of 683,000 units at $10.00 to the Prior Sponsor and BTIG, LLC generated gross proceeds of $6,830,000.

Recent performance

The company reported annual net income of $4.7 million for 2025, its first full fiscal year, driven by non-operating income because it has no operations. Operating cash flow for 2025 was negative $938,877. As of June 30, 2026, total assets were $263.5 million, total liabilities were $9.6 million, shareholder equity was negative $9.5 million, and cash and equivalents were $32,560. No operating revenue was recorded in any period.

Strategy

Management's stated purpose is to identify and negotiate a business combination with one or more businesses, with an expected focus on biotechnology, healthcare and technology companies. The company raised $253.0 million in its June 2025 IPO and $6.83 million in a concurrent private placement to fund that search and to hold in trust. As of the June 30, 2026 10-Q, it had not commenced operations or completed a business combination. The Class B Founder Shares held by the Prior Sponsor will convert into Class A ordinary shares on a one-for-one basis at or immediately following the consummation of an initial business combination.

Risks

• No operating business — The company has no material operations and will not generate operating revenues until at least the completion of an initial business combination.
• Sponsor voting control — If a shareholder vote is held, the Sponsor will participate and vote in favor of the business combination, so it may be completed even if holders of a majority of Public Shares do not approve.
• Negative shareholder equity — Shareholder equity was negative $9.5 million at June 30, 2026, alongside total liabilities of $9.6 million.
• Dependence on trust proceeds — The company's ability to fund a business combination depends on IPO and private placement proceeds, as cash and equivalents were only $32,560 at June 30, 2026.

Outlook

Management continues to search for and negotiate a potential business combination, expecting to focus on biotechnology, healthcare and technology companies. The company states it will not generate operating revenue until after a business combination is completed. No specific combination target, timeline or terms are disclosed in the provided excerpts.